Focal Medical
Cary
About Focal Medical
Focal Medical, Inc. is a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative and patent protected targeted therapeutic system. The Company’s lead product is a targeted therapeutic product delivering gemcitabine (an FDA approved chemotherapeutic) actively and directly to the pancreas by non-circulatory pathways to treat pancreatic cancer. Focal Medical, Inc. is formerly known as Advanced Chemotherapy Technologies, Inc. It is headquartered in Cary, North Carolina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.5M
- Funding stage: M&A
- Last round: Series A (Sep 2020)
- Website: focalmedical.co
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/focal-medical-15352 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.